S&P TSX Capped Composite...

US Dollar vs CAD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

SONN Sonnet BioTherapeutics Holdings Inc

2.98

0.09 (3.11%)

Nov 22 2024 - Closed

Delayed by 15 minutes

Form EFFECT - Notice of Effectiveness

Sonnet BioTherapeutics (NASDAQ:SONN)
Historical Stock Chart
From Oct 2024 to Nov 2024

Click Here for more Sonnet BioTherapeutics Charts.

Sonnet BioTherapeutics (NASDAQ:SONN)
Historical Stock Chart
From Nov 2023 to Nov 2024

Click Here for more Sonnet BioTherapeutics Charts.

Sonnet BioTherapeutics Holdings Inc News

Sonnet BioTherapeutics Releases Virtual Investor ‘”What this Means” Segment
Tuesday 12 November 2024 (2 weeks ago) • GlobeNewswire Inc.

Form 8-K - Current report
Friday 8 November 2024 (2 weeks ago) • Edgar (US Regulatory)

Form 424B4 - Prospectus [Rule 424(b)(4)]
Thursday 7 November 2024 (2 weeks ago) • Edgar (US Regulatory)

Form EFFECT - Notice of Effectiveness
Wednesday 6 November 2024 (2 weeks ago) • Edgar (US Regulatory)

Sonnet BioTherapeutics Announces Pricing of $5.0 Million Underwritten Public Offering Priced At-The-Market Under Nasdaq Rules
Wednesday 6 November 2024 (3 weeks ago) • GlobeNewswire Inc.

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Wednesday 6 November 2024 (3 weeks ago) • Edgar (US Regulatory)

Form 8-K - Current report
Wednesday 6 November 2024 (3 weeks ago) • Edgar (US Regulatory)

Sonnet BioTherapeutics Announces Issuance of U.S. Patent Covering a Variant IL-18 Incorporated into Two Novel Immunotherapeutic Drug Candidates
Wednesday 6 November 2024 (3 weeks ago) • GlobeNewswire Inc.

Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
Monday 4 November 2024 (3 weeks ago) • Edgar (US Regulatory)

Form S-1 - General form for registration of securities under the Securities Act of 1933
Monday 28 October 2024 (4 weeks ago) • Edgar (US Regulatory)

Form 8-K - Current report
Thursday 17 October 2024 (1 month ago) • Edgar (US Regulatory)

Sonnet BioTherapeutics Inc. Regains Compliance with Nasdaq
Thursday 17 October 2024 (1 month ago) • GlobeNewswire Inc.

More Sonnet BioTherapeutics Holdings Inc News Articles

Global Developments (PK)

Baron Capital Enterprise (CE)

Anavex Life Sciences

Northwest Biotherapeutics (QB)

Kraig Biocraft Laborator... (QB)

Bioelectronics (PK)

Rennova Health (CE)

Lightwave Logic

Elite Pharmaceuticals (QB)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions